They may be the window to the soul, but researchers have found the eyes also give an insight into the brain that could help ...

They may be the window to the soul, but researchers have found the eyes also give an insight into the brain that could help ...

Symptoms usually increase over a period ... isolated syndrome act similarly in their conversion to MS. Patients with optic neuritis as a first demyelinating event tend to have brain MRI lesions ...

The symptoms of MS vary from person to person ... vision problems may be the first signs of MS. This can present commonly as optic neuritis, which is an inflammation of the optic nerve that ...

Demyelinating optic neuritis (DON) is a hallmark feature of multiple sclerosis (MS ... macula from fluid leakage in the subretinal space; symptoms may be similar to DON with sudden-onset blurred ...

In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...

This concept changed with the discovery of serum antibodies (Ab) against aquaporin-4 (AQP4), which unequivocally differentiate NMO from MS. Patients who test positive for AQP4-Abs and present with ...

Others are used to manage resulting symptoms like pain, depression, and muscle stiffness. There are several types of medications that can be used to treat MS, including chemotherapy drugs, ...

DMTs are not used to treat individual relapses or daily MS symptoms. Moderate to severe MS relapses are typically treated with a high-dose, anti-inflammatory corticosteroid like Solu-Medrol ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...